1 Min Read
June 8 (Reuters) - Edge Therapeutics Inc
* Edge Therapeutics receives pediatric investigation plan waiver from the European medicines agency Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.